The health‑insurance sector is at the center of market turbulence today, as a proposed 2027 Medicare Advantage payment update from the Trump administration forced investors and insurers alike to rapidly reassess earnings trajectories, capital plans and product strategy.
While the broader equity market was mixed to positive—anchored by strength in technology and a new record high for the S&P 500—major managed‑care names suffered a sharp, sector‑specific repricing that wiped out tens of billions of dollars in market value in a matter of hours.
At issue is a proposal from the Centers for Medicare and Medicaid Services that would raise average Medicare Advantage payment rates by just 0.09% in 2027, dramatically below the 4% to 6% increase many on Wall Street and in the industry had penciled into their models.
For practical purposes, health‑plan executives are treating the figure less as a rate increase than as a real‑terms reduction, once medical cost trends, utilization, wage inflation and benefit pressures are taken into account.
The market reaction was immediate and severe:
The selloff was particularly punishing given the sector’s prior reliance on Medicare Advantage as a primary growth engine. For years, rich federal payments and favorable risk‑adjustment dynamics allowed plans to expand benefits, hold premiums down and still deliver robust margins. Today’s proposal abruptly challenges that playbook.
Reed Fraasa, founder and wealth advisor at Wayne, New Jersey-based RIA Highland Financial Advisors shrugged off today's healthcare tumult. “We’re not making any changes to our clients’ allocation because of the Trump administration’s proposals for healthcare,” Fraasa told Investment News. “We have seen similar proposals before and they don’t always go anywhere.
“News like this is not a reason for us to have a knee-jerk reaction,” he added. “We are not stock traders, we are long-term asset allocation investments that are built around a financial plan.”
Wayne George, a financial advisor at New York City-based RIA Nuvern Wealth Advisors expressed a similar sentiment. “In regards to the healthcare sector, whether individual stocks or ETFs, we focus on long-term prospects rather than the short-term swings,” he told Investment News, while acknowledging that healthcare stocks have fallen recently.
“We keep the conversation focused on whether the client's exposure still makes sense for their overall financial plan,” he added. “Our role is mainly to help clients stay grounded and disciplined in that context rather than reacting to recent price action or the headlines.”
UnitedHealth compounded investor anxiety by pairing the policy shock with softer‑than‑expected 2026 revenue guidance and hefty charges, reinforcing concerns that the Medicare book may already be under earnings pressure even before 2027 rates take effect.
Humana, long one of the purest Medicare Advantage plays in the public market, was hit particularly hard as investors questioned how much of its growth algorithm depends on richer reimbursement assumptions.
If the proposal is finalized as written, many carriers will be forced into a difficult trade‑off in the 2027 bid cycle:
Neither option is especially attractive in a political environment that is increasingly focused on both Medicare’s fiscal sustainability and consumer affordability.
The agency framed the move as a step toward more accurate and sustainable payments. CMS officials said the proposal is intended to modernize risk adjustment and ensure that plans are reimbursed appropriately for “real health needs,” while protecting taxpayers from excess spending that is not tied to genuine clinical risk.
“These proposed payment policies are about making sure Medicare Advantage works better for the people it serves,” CMS Administrator Mehmet Oz said in announcing the measures.
More than half of Medicare beneficiaries are now enrolled in Medicare Advantage, lured by lower or zero‑dollar premiums and benefits that traditional Medicare does not cover. That popularity has made the program central not only to the business models of large carriers, but also to federal budget debates. As enrollment has grown, so has policymakers’ focus on curbing perceived overpayments and tightening guardrails.
The day’s market moves also highlighted a growing divergence within insurance subsectors. While health insurers absorbed a concentrated shock, life and property‑and‑casualty names were far more stable.
Among notable intraday moves:
Additional reporting by James Rogers.
RIA aggregator adds $4.8 billion in client assets across seven states as demand grows for alternatives to traditional succession models.
As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management
Shareholder targets FS KKR Capital's directors over alleged portfolio valuation and dividend missteps.
UBS has a history of costly litigation stemming from the sale of volatile investment products.
New director David Woodcock puts firms on notice over fees, conflicts, and liquidity risk as private credit shows signs of stress.
As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management
Growth may get the headlines, but in my experience, longevity is earned through structure, culture, and discipline
